Patient characteristics correlate with toxicity, response to CAR T-cell therapy in diffuse large B-cell lymphoma – Healio
|
Patient characteristics correlate with toxicity, response to CAR T-cell therapy in diffuse large B-cell lymphoma
Healio “JCAR017, a defined composition chimeric antigen receptor [CAR] T-cell product administered at precise doses of CD4-positive and CD8-positive CAR T cells, better enables the identification of potential patient factors associated with clinical outcomes … |
